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Abstract 53 
Background: Prospective cohort studies have indicated that serum vitamin D levels are 54 
inversely related to risk of type 2 diabetes. However, such studies cannot determine the source 55 
of vitamin D. Therefore, we examined the association of dietary vitamin D intake with 56 
incident type 2 diabetes within the European Prospective Investigation into Cancer and 57 
Nutrition (EPIC)-InterAct study in a heterogeneous European population including 8 58 
countries with large geographical variation. 59 
Methods: Using a case-cohort design, 11,245 incident cases of type 2 diabetes and a 60 
representative subcohort (N=15,798) were included in the analyses. Hazard ratios (HR) and 61 
95% confidence intervals (CIs) for type 2 diabetes were calculated using a Prentice-weighted 62 
Cox regression adjusted for potential confounders. 24-h diet recall data from a subsample 63 
(N=2347) were used to calibrate habitual intake data derived from dietary questionnaires. 64 
Results: Median follow-up time was 10.8 years. Dietary vitamin D intake was not 65 
significantly associated with the risk of type 2 diabetes. HR and 95 % CIs for the highest 66 
compared to the lowest quintile of uncalibrated vitamin D intake was 1.09 (0.97-1.22), 67 
(ptrend=0.17). No associations were observed in a sex-specific analysis. The overall pooled 68 
effect [HR (95% CI)] using the continuous calibrated variable was 1.00 (0.97-1.03) per 69 
increase of 1 µg/day dietary vitamin D.  70 
Conclusion: This observational study does not support an association between higher dietary 71 
vitamin D intake and type-2 diabetes incidence. This result has to be interpreted in light of the 72 
limited contribution of dietary vitamin D on the overall vitamin D status of a person.  73 
 74 
Keywords: vitamin D, type-2 diabetes, dietary intake, observational study, EPIC 75 
76 
 3 
Introduction 77 
Besides the ‘classical’ function of vitamin D in calcium homeostasis, additional biological 78 
effects of vitamin D on diabetes-related outcomes have been identified. The results of 79 
experimental cell, animal and human studies support a role of vitamin D in the prevention of 80 
type 2 diabetes.1-4 However, the mechanisms by which vitamin D may affect type 2 diabetes 81 
risk are not fully understood. Effects of vitamin D on insulin secretion, insulin sensitivity as 82 
well as on inflammatory and autoimmune conditions associated with diabetic conditions are 83 
reported.4-9  84 
Evidence from prospective observational studies for an inverse association between vitamin D 85 
status, as characterized by serum 25-hydroxyvitamin D [25(OH)D] measurements, and type 2 86 
diabetes is strong.10-12 After combining the data from nine prospective studies that measured 87 
serum 25(OH)D, participants in the highest (versus lowest) quartile of 25(OH)D showed a 88 
41% (95% CI, 33%, 48%) lower risk of type-2 diabetes though any causal inference of this 89 
association remains unconfirmed.13 Moreover, a recent metaanalysis combining results from 90 
14 observational studies reported a significant inverse association for circulating 25(OH)D 91 
but not for dietary vitamin D.14 Serum 25(OH)D concentration, the accepted biomarker of 92 
vitamin D status, reflects both the endogenous synthesis in the skin (following UVB 93 
exposure) and the dietary intake of vitamin D. Though in general the contribution of dietary 94 
vitamin D to the overall vitamin D status is of minor importance as compared to the 95 
endogenous synthesis of vitamin D, intra- and inter-subject variation in UVB exposure can be 96 
high, and the importance of vitamin D from diet substantially increases in situations with 97 
limited UVB exposure. Thus, analyses on the impact of dietary vitamin D and diabetes risk 98 
are meaningful. Mitri and colleagues combined data from three cohort studies and found a 99 
borderline significant inverse association between vitamin D intake >500 U/d (12.5 µg/d) and 100 
type 2 diabetes incidence (versus subjects with a vitamin D intake < 200 U/d (5 µg/d)); the 101 
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relative risk was 0.87 (95% CI, 0.76-0.99).11 However, only one out of three cohort studies 102 
reported a significant inverse association.15-17 103 
 104 
Due to its large sample size, the InterAct project within the European Prospective 105 
Investigation into Cancer and Nutrition (EPIC) provides the opportunity to investigate the 106 
association between the incidence of type 2 diabetes and dietary vitamin D prospectively in 107 
both men and women. Furthermore, the study allows a relatively wide range of dietary intake 108 
levels since data from different European countries are included. 109 
 110 
Material and Methods 111 
Study design and population 112 
EPIC is a multi-centre prospective cohort study conducted since 1992 in 10 European 113 
countries.18 In the present EPIC-InterAct study, a nested case-cohort design within 8 of the 10 114 
countries contributing to the EPIC cohort was used.19 The current analysis is based on data 115 
from EPIC participants in Denmark, France, Germany, Italy, the Netherlands, Spain, Sweden, 116 
and the United Kingdom (UK).  117 
Following the case-cohort design, the study population consisted of a random baseline sample 118 
of 16.154 participants (subcohort) and 12.403 incident cases of type 2 diabetes (including 778 119 
from the subcohort), i.e. all participants of the entire cohort with a first diagnosis of type 2 120 
diabetes between recruitment and December 31, 2007.19 121 
The final study sample after excluding participants without dietary information (N=736) 122 
consisted of 27,043 participants, including 15,798 members of the subcohort and 11,994 123 
incident diabetes cases (including 749 cases from the subcohort). 124 
Dietary assessment 125 
Diet over the previous twelve months was assessed using dietary assessment instruments that 126 
were specifically developed for each participating country.18 The questions were structured by 127 
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common food groups except for the questionnaires used in Italy and Spain, where questions 128 
were structured by country-specific meals. 129 
All participants were asked to report their average consumption of each food by structured 130 
categories ranging from never or less than once per month to six or more times per day. In 131 
Germany, Italy, The Netherlands and Spain individual average portions were estimated, 132 
whereas standard portions were assigned to the participants in Denmark, the United Kingdom 133 
and Umeå, Sweden. A combination of methods for estimating portion size was used in 134 
Malmo, Sweden. All dietary measurement instruments have been validated previously in a 135 
series of studies within the various source populations participating in EPIC.20 136 
Daily intake of vitamin D, calcium, and magnesium was calculated by means of a 137 
standardized food composition data base across EPIC countries 21. 138 
 139 
Demographic and lifestyle factors 140 
To collect information on education, medical history (surgeries and previous illnesses), 141 
tobacco and alcohol consumption, and physical activity and other lifestyle factors, additional 142 
questionnaires were used. Height and weight were measured at baseline, except for the France 143 
and Oxford-UK study centre, where height and weight was self-reported.18 144 
Ascertainment of type 2 diabetes 145 
Ascertainment and verification of incident diabetes has been described in detail elsewhere.19 146 
In brief, incident cases were identified by self-reports (history of diabetes, physician-147 
diagnosed diabetes, antidiabetic drug use), linkage to primary and secondary care registers, 148 
linkage to drug registers, hospital admissions and mortality data. Further verification of the 149 
diabetic cases came from individual medical record reviews.  150 
Statistical analysis 151 
Cox proportional hazard models adapted for case-cohort design according to the Prentice 152 
method were used to calculate hazard ratios (HR) and 95% confidence intervals (CI).22 A Cox 153 
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model was used with stratification by age (in 1-year categories), centre and sex; Incident type 154 
2 diabetes was the outcome variable and age was used as the underlying timescale.  155 
Hazard ratios for dietary vitamin D intake are presented comparing quintiles taking the lowest 156 
quintile as reference. Quintile cutpoints were defined among subcohort members only. 157 
Different models were run to disentangle the effects of dietary vitamin D on type 2 diabetes: 158 
model 1: adjusted for total energy (kcal/day, cont.); model 2: adjusted for non-fat-energy 159 
(kcal/day, cont.), fat (g/day, cont., monounsaturated, polyunsaturated and saturated fat), 160 
physical activity (occupational, recreational and household activity; inactive, moderately 161 
inactive, moderately active, active, missing)23, and model 3: as model 2 with further 162 
adjustment for a-priori defined potential confounders and risk factors for diabetes: BMI 163 
(kg/m2, cont.), education level (none or primary school, technical/professional school, 164 
secondary school, longer education incl. university degree, unknown), smoking status (never, 165 
former, current, unknown), alcohol intake (g/day, cont.). Sensitivity analyses were performed 166 
excluding incident cases that occurred within the first two years of follow-up as well as 167 
additional adjustment for waist-hip-ratio. 168 
In order to account for different levels of sunlight exposure, the EPIC centres were divided 169 
into 7 latitude group: below 42°N (Granada, Murcia, Ragusa, and Naples); 42°N - 44°N 170 
(Asturias, Navarra, San Sebastian, Florence, and South coast of France – centred in 171 
Marseille); 45°N - 46°N (Varese, Turin, and South of France – centred in Lyon); 47°N - 49°N  172 
(North-East and West of France – centred in Nantes and Paris, respectively – and 173 
Heidelberg); 50°N  - 51°N  (Potsdam, Utrecht, Bilthoven, Cambridge, and Oxford); 52°N  - 174 
56°N  (Malmö, Aarhus, and Copenhagen); and above 57°N  (Norway, and Umeå). A further 175 
sensitivity analysis was thus performed with additional adjustment for latitude. 176 
Statistical interaction (heterogeneity) was evaluated with the Wald test by including cross-177 
product terms of potential interaction variables (i.e., sex, physical activity, BMI) in the 178 
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respective models. Tests for trend over quintiles of intake (coded 1 to 5) were performed 179 
using the Wald statistics. 180 
 181 
To correct for measurement error, dietary intake data calculated from questionnaire data were 182 
calibrated against 24 hour dietary recall data for a subsample (N = 2347). A fixed-effects 183 
linear model was used in which centre and sex-specific recall data were regressed on the 184 
dietary intakes.24-26 The calibrated dietary data were used to model dietary intake of vitamin D 185 
continuously in the whole sample and in the country-specific analysis. We used a meta-186 
analytic approach to investigate heterogeneity across centres (metan procedure in STATA) by 187 
pooling the adjusted HR’s per centre using the random effects model. 188 
All tests were two-sided and considered to be statistically significant with a p-value of d0.05. 189 
All analyses were conducted using SAS version 9.1 (SAS Institute, Cary, North Carolina) and 190 
STATA version 10 for meta-analysis (College Station, Texas).  191 
 192 
Results 193 
Median vitamin D intake in the subcohorts of the respective countries by sex is shown in 194 
Table 1. Dietary vitamin D intake was highest in Sweden and lowest in Italy. Vitamin D 195 
intake was higher in men across all countries. 196 
Median age at baseline was 52.7 years (IQR 46.5-59.2). The median follow-up time for the 197 
study population was 10.8 years. Descriptive characteristics of the subcohort by quintiles of 198 
vitamin D intake are shown in Table 2. The percentage of current smokers was lower in men 199 
but higher in women with higher vitamin D intake. The increasing numbers of participants 200 
with unknown physical activity with increasing vitamin D intake is due to physical activity 201 
data not being collected in Umeå, Sweden, where vitamin D intake is high. No differences in 202 
BMI were observed by quintiles of vitamin D intake. Total fish, meat, calcium and energy 203 
intake was higher in both men and women with increasing vitamin D intake (table 2).  204 
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No significant association was observed between vitamin D intake and type 2 diabetes risk 205 
(Table 3). Hazard ratios (HR) and 95 % confidence intervals (CI) in the most adjusted model 206 
for the higher quintiles compared to the lowest were 1.04 (0.95-1.14), 1.02 (0.93-1.12), 1.06 207 
(0.96-1.17) and 1.09 (0.97-1.22) (p-trend=0.17) (Table 3). We further performed a separate 208 
analysis by sex and did not find any significant association between diabetes incidence and 209 
vitamin D intake in either men or women (pinteraction = 0.40). No statistical interaction was 210 
observed between BMI or physical activity groups and dietary vitamin D (pinteraction> 0.05). 211 
Moreover, there was no statistical interaction between vitamin D and calcium intake (p = 212 
0.93). 213 
To account for potential measurement error when calculating dietary intake from 214 
questionnaire data, we further performed an analysis using the continuous intake data 215 
calibrated with 24-hr dietary recall data from a subsample of the subcohort. The overall 216 
estimate showed no association for vitamin D and diabetes risk [HR (95% CI) =1.00 (0.97-217 
1.03), per 1 µg/day increment] (Figure 1). The corresponding effect estimate using the 218 
observed (continuous) data was HR (95% CI) =1.03 (0.98-1.08). Country specific hazard 219 
ratios for the calibrated vitamin D intake (per 1 µg/day increment) in comparison with the 220 
overall effect estimate are shown in the forest plot (Figure 1). There was statistically 221 
significant heterogeneity across countries (I2=60.9%, p = 0.012). Heterogeneity could in part 222 
be explained by the significant positive association in the UK data as exclusion of the UK 223 
data resulted in a non-significant and substantially decreased heterogeneity (I2=18.6%, p = 224 
0.228). In a sensitivity analysis, we excluded incident cases that occurred within the first two 225 
years of follow-up. No considerable changes in the hazard ratios were observed. We 226 
furthermore additionally adjusted for waist-hip-ratio and did not observe any changes in the 227 
effect estimates (waist-hip-ratio data are missing for the Umeå centre, n = 1796). As a proxy 228 
for sun exposure and thus endogenous vitamin D production we divided the centres in 7 229 
categories according to their latitude. Adjustment for latitude did not notably change the 230 
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observed risk estimates for vitamin D and typ-2 diabetes risk. Furthermore, additional 231 
adjustment for calcium intake did not notably change the risk estimates. 232 
 233 
Discussion 234 
In this large prospective case-cohort analysis within the European Prospective Investigation 235 
into Cancer and Nutrition dietary vitamin D was not significantly associated with the 236 
incidence of type 2 diabetes. This was true for men and women. So far, only few cohort 237 
studies prospectively assessed the association between dietary vitamin D with the incidence of 238 
type 2 diabetes or diabetes related outcomes.15-17 In line with our results, the Nurses’ Health 239 
Study did not find a significant association between dietary or total intake of vitamin D and 240 
type 2 diabetes.16 Furthermore, our results corroborate the findings from a large Japanese 241 
cohort that reported no association in men or in women.17 However, the Women’s Health 242 
Study reported an inverse association between dietary vitamin D intake and the prevalence of 243 
metabolic syndrome15, and also a meta-analysis of these three studies found a borderline 244 
inverse association between vitamin D intake >500 U/d (>12.5 µg/d) and type 2 diabetes 245 
incidence.11  246 
Systematic reviews focusing on eight randomized trials did also not provide clear evidence 247 
for an inverse association of vitamin D supplementation with hyperglycemia or incident type 248 
2 diabetes.11 The so far largest trial, the Women’s Health Initiative (WHI) study, did not 249 
observe any risk reduction of type 2 diabetes over 7 years of follow-up in the intervention arm 250 
with supplementation of vitamin D (400 IU/d) and calcium (1000 mg/d).27 However, the 251 
authors noted, that higher doses of vitamin D may have been necessary to affect diabetes risk.  252 
Several explanations are possible as to why we did not observe any association between 253 
dietary vitamin D and type 2 diabetes risk in our study: 1) there is indeed no relationship; 2) 254 
the amount and variation of dietary vitamin D intake is too low in the population to detect 255 
potential effects; especially, dietary vitamin D intake is distinctly lower in most European 256 
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countries as compared to the US where staple food is frequently fortified with vitamin D, and 257 
thus dietary vitamin D intake more effectively impacts on the overall vitamin D status of a 258 
person.  259 
The present study is thus far the largest study prospectively assessing the association between 260 
dietary vitamin D intake and the risk of type 2 diabetes. Thus, power was high to detect even 261 
weak associations. Further strengths of the study were the high quality of physician-verified 262 
diagnoses of type 2 diabetes; the calibration of nutrient intake data from questionnaires with 263 
that from 24 h recall data; and the inclusion of detailed information on potential confounders 264 
in the analysis. However, due to the observational study design, residual confounding cannot 265 
completely be ruled out. A further strength of the study is the wide range of intake from 266 
different European countries with different eating habits. The intake data in our study was 267 
comparable to that in representative studies in Europe.28-30 Particularly, the here presented 268 
higher intake in the northern European countries, e.g. Sweden, where intake of vitamin D-rich 269 
foods and the contribution from fortified foods is high, is in line with previous reports.28,31 270 
There are, however, several limitations that should be noted when interpreting the results. 271 
Firstly, we did not account for vitamin D from supplements. Additional adjustment on 272 
unspecified supplement intake in the study population did not change the risk estimates, but 273 
calculated amounts of vitamin D from supplements were not available. Secondly, the 274 
contribution of endogenous production of vitamin D (following UVB exposure) could not be 275 
addressed here. In a sensitivity analysis, we adjusted for centers’ latitude as a proxy for sun 276 
exposure, which did not affect the risk estimates. However, since the contribution of diet to 277 
the overall vitamin D status of a person is low, studies with information on the entire vitamin 278 
D status may lead to a different conclusion. Indeed, prospective observational studies with 279 
serum 25(OH)D measurements showed a strong inverse association between vitamin D status 280 
and type 2 diabetes.10-13 However, these studies can also be subject to substantial residual 281 
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confounding, e.g. by imprecise assessment of outdoor physical activities which are correlated 282 
with both UVB exposure and, eventually, with vitamin D status as well as with diabetes risk. 283 
In summary, in the present study we did not observe an association between dietary vitamin D 284 
intake and the risk of type 2 diabetes in a large European study population. However, it has to 285 
be acknowledged that endogenous production of vitamin D in the skin following UVB 286 
exposure is the dominant predictor of vitamin D status in humans. 287 
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TABLE 1 Dietary vitamin D intake by sex and country  413 
in the subcohort1: the EPIC-InterAct study 414 
 415 
Country 
Men Women 
Median IQR Median IQR 
All 3.6 1.6-7.7 2.4 1.1-4.6 
France -- -- 1.3 0.7-2.5 
Italy 1.3 0.8-2.7 1.0 0.5-2.1 
Spain 2.7 1.3-8.7 1.7 0.9-4.4 
UK 3.5 1.7-5.2 2.4 1.7-3.8 
Netherlands 3.4 2.3-7.4 2.5 1.8-3.9 
Germany 2.0 1.1-3.6 1.5 0.8-3.3 
Sweden 7.1 4.5-9.6 4.7 3.3-6.7 
Denmark 2.9 1.4-7.7 1.7 1.0-3.9 
1 Vitamin D intake in µg/day from 24-hour recall data (N =2347); IQR, inter-quartile range 416 
 417 
418 
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TABLE 2 Baseline characteristics in the subcohort by sex and quintiles of dietary vitamin D intake: the EPIC-InterAct study 
 
Vitamin D (µg/day) Quintile 1 
< 2.19 
(Median: 1.6) 
Quintile 2 
2.19-<3.13 
(Median: 2.6) 
Quintile 3 
3.13-<4.27 
(Median: 3.7) 
Quintile 4 
4.27-<6.07 
(Median: 5.0) 
Quintile 5 
e6.07 
(Median: 7.9) 
Men  N % N % N % N % N % 
 N = 744 N = 903 N = 1109 N = 1418 N = 1794 
Smoking status           
   Never 201 27 275 30 353 32 461 33 591 33 
   Former 278 37 349 39 402 36 515 36 627 35 
   Current 259 35 269 30 333 30 430 30 567 32 
   Unknown 6 1 10 1 21 2 12 1 9 1 
Education           
   Primary school or less 348 47 335 37 413 37 502 35 731 42 
   Technical/professional 
school 140 19 200 22 260 23 351 25 388 22 
   Other secondary 
education 92 12 133 15 132 12 160 11 260 14 
   University 154 21 220 24 281 25 385 27 398 22 
   Unknown 10 1 15 2 23 2 20 1 17 1 
Physical activity           
   Inactive 201 27 258 29 284 26 374 26 348 19 
   Moderately inactive 243 33 274 30 339 31 397 28 603 34 
   Moderately active 224 30 261 29 314 28 359 25 474 26 
 20 
   Active 60 8 79 9 91 8 114 8 108 6 
   Unknown 16 2 31 3 81 7 174 12 261 15 
           
 Median IQR Median IQR Median IQR Median IQR Median IQR 
Age at recruitment 52.7 46.3-58.4 52.8 45.9-58.5 52.9 46.5- 58.6 53.0 47.3- 59.6 53.8 48.6- 60.3 
BMI (kg/m2) 26.7 24.5-28.9 26.4 24.1-28.8 26.2 24.2-28.6 26.3 24.5-28.7 26.2 24.0-28.7 
Total energy (Kcal/d) 2048 1685-2457 2256 1860-2713 2330 1963-2736 2443 2052-2869 2678 2273-3150 
Saturated fat (g/d) 24.5 18.6-31.0 30.1 23.4-37.4 32.2 24.9-40.8 34.8 27.0-43.5 41.2 31.8-52.4 
Monounsaturated fat 
(g/d) 28.3 21.0-38.9 31.5 23.0-41.9 31.5 24.3-42.0 33.6 26.5-42.7 39.2 31.6-48.7 
Polyunsaturated fat (g/d) 9.9 7.6-13.6 11.6 9.2-15.3 13.2 10.4-16.8 14.0 10.9-18.4 16.7 13.2-21.7 
Alcohol (g/d) 13.5 3.1-34.0 16.3 5.4-38.4 16.4 5.2-37.3 14.8 4.9-37.8 13.2 4.1-31.0 
Calcium (mg/d) 804 595-1047 885 669-1173 931 720-1233 968 735-1261 1109 836-1400 
Magnesium (g/d) 335 267-410 351 295-421 369 312-438 391 323-458 412 347-483 
Coffee (g/d) 120 56-413 175 65-500 287 90-600 385 131-665 400 145-675 
Soft drinks (g/d) 0.0 0.0-39.4 6.7 0.0-66.7 8.1 0.0-85.7 16.4 0.0-97.5 21.3 0.0-114 
Total meat (g/d) 101 66-146 119 86-159 130 91-170 134 98-178 142 102-193 
Total fish (g/d) 10.0 3.1-22.4 16.4 8.2-28.4 22.7 12.7-36.3 29.4 15.3-47.6 37.7 15.4-67.7 
           
 21 
Vitamin D (µg/day) Quintile 1 
< 2.19 
(Median: 1.6) 
Quintile 2 
2.19-<3.13 
(Median: 2.6) 
Quintile 3 
3.13-<4.27 
(Median: 3.7) 
Quintile 4 
4.27-<6.07 
(Median: 5.0) 
Quintile 5 
e6.07 
(Median: 7.9) 
Women N % N % N % N % N % 
 N = 2415 N = 2257 N = 2050 N = 1742 N = 1366 
Smoking status           
   Never 1416 59 1244 55 1143 56 963 55 694 51 
   Former 482 20 523 23 440 21 350 20 296 22 
   Current 494 20 476 21 447 22 408 23 367 27 
   Unknown 23 1 14 1 20 1 21 1 9 1 
Education           
   Primary school or less 1077 45 916 41 780 38 672 39 571 42 
   Technical/professional 
school 443 18 499 22 508 25 447 26 366 27 
   Other secondary 
education 438 18 393 17 363 18 249 14 157 11 
   University 420 17 408 18 356 17 339 19 255 19 
   Unknown 37 2 41 2 43 2 35 2 17 1 
Physical activity           
   Inactive 274 11 263 12 248 12 197 11 151 11 
   Moderately inactive 611 25 551 24 466 23 435 25 418 31 
   Moderately active 1237 51 1111 49 951 46 769 44 588 43 
 22 
   Active 244 10 238 11 214 10 156 9 102 7 
   unknown 49 2 94 4 171 8 185 11 107 8 
 Median IQR Median IQR Median IQR Median IQR Median IQR 
Age at recruitment 52.3 45.3-58.8 52.4 46.3-58.7 51.9 46.0-58.5 52.1 46.1-59.3 53.3 47.1-61.0 
BMI (kg/m2) 24.9 22.4-28.3 24.9 22.5-27.9 25.0 22.6-28.1 24.7 22.5-28.0 25.0 22.6-28.2 
Total energy (Kcal/d) 1625 1353-1926 1836 1529-2185 1916 1604-2282 2001 1695-2404 2185 1861-2563 
Saturated fat (g/d) 22.1 16.5-27.8 27.0 21.1-34.0 28.5 21.8-36.3 30.7 24.1-39.0 35.2 26.7-44.0 
Monounsaturated fat 
(g/d) 22.3 16.3-30.5 25.4 19.1-33.8 26.4 20.5-35.0 27.8 22.4-35.8 32.3 26.3-40.2 
Polyunsaturated fat (g/d) 8.8 6.8-11.4 10.7 8.4-14.0 11.5 8.9-14.7 12.3 9.4-16.4 14.2 11.3-18.2 
Alcohol (g/d) 1.9 0.0-10.1 3.0 0.3-11.6 3.7 0.4-11.6 4.0 0.6-12.1 5.0 0.7-12.8 
Calcium (mg/d) 806 614-1033 904 711-1147 957 727-1212 995 770-1244 1062 861-1326 
Magnesium (g/d) 283 233-343 309 257-369 327 275-386 337 283-404 348 300-408 
Coffee (g/d) 150 58-437 250 84-500 290 100-523 330 129-582 375 150-600 
Soft drinks (g/d) 0.0 0.0-36.2 0.0 0.0-46.2 3.3 0.0-55.7 6.5 0.0-85.7 6.0 0.0-85.7 
Total meat (g/d) 75 47-106 91 62-120 94 65-129 95 68-126 99 71-131 
Total fish (g/d) 9.5 3.2-21.5 16.1 7.0-29.7 22.7 9.8-36.0 27.2 11.2-46.3 37.8 17.4-66.2 
    N = 15798; IQR: inter-quartile range 
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TABLE 3 Dietary vitamin D intake and risk of type 2 diabetes: the EPIC-InterAct study 
 Model 11  Model 21  Model 31 
Quintiles of vitamin D 
intake (µg/day) 
HR 95% CI  HR 95% CI  HR 95% CI 
< 2.19 Ref.   Ref.   Ref.  
2.19-<3.13 1.04 (0.96 - 
1.13) 
 1.02 (0.94-
1.11) 
 1.04 (0.95-
1.14) 
3.13-<4.27 1.02 (0.94 - 
1.11) 
 1.00 (0.91-
1.08) 
 1.02 (0.93-
1.12) 
4.27-<6.07 1.09 (1.00 - 
1.19) 
 1.05 (0.96-
1.15) 
 1.06 (0.96-
1.17) 
e6.07 1.18 (1.06 - 
1.30) 
 1.10 (0.99-
1.22) 
 1.09 (0.97-
1.22) 
p-trend 0.002   0.078   0.170  
1 All models stratified by sex, age and study centre; model 1: adjustment for total energy; model 2: adjustment for non-fat energy, polyunsaturated 
fatty acids, monounsaturated fatty acids, saturated fatty acids, physical activity; model 3: as model 2 with further adjustment for education, BMI, 
smoking, alcohol intake; HR = hazard ratio, CI = confidence interval. 
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FIGURE 1 Dietary vitamin D intake (per 1 µg/day) and risk of type 2 diabetes, by country 
and overall: the EPIC-InterAct study; CI = confidence interval. 
(Models stratified by sex and age; adjusted for non-fat energy, polyunsaturated fatty acids, 
monounsaturated fatty acids, saturated fatty acids, physical activity, education, BMI, 
smoking, alcohol intake.) 
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